Graf Akcie BHC (Bausch Health Companies Inc). Diskuze k akciím BHC. Aktuální informace BHC.

Základní informace o společnosti Bausch Health Companies Inc (Akcie BHC)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 10.01B
Hodnota podniku (EV) 32.91B
Tržby 8.478B
EBITDA 3.109B
Zisk -1.29
Růst v tržbách Q/Q 26.20 %
Růst v tržbách Y/Y 4.55 %
P/E (Cena vůči ziskům) N/A
Forward P/E 0.01
EV/Sales 3.88
EV/EBITDA 10.58
EV/EBIT N/A
PEG 0.87
Price/Sales 1.18
P/FCF 8.41
Price/Book 18.71
Účetní hodnota na akcii 1.49
Hotovost na akcii 5.05
FCF vůči ceně 11.89 %
Počet zaměstnanců 21,600
Tržba na zaměstnance 392.500k
Profit margin -6.98 %
Operating margin -0.42 %
Gross margin 71.98 %
EBIT margin -1.18 %
EBITDA margin 36.67 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 110.87 %
EPS - Očekávaný růst příští rok -20.45 %
Return on assets -4.19 %
Return on equity -2,163.03 %
ROIC 1.85 %
ROCE -0.41 %
Dluhy/Equity 57.19
Čistý dluh/EBITDA 28.27
Current ratio 0.99
Quick Ratio 0.79
Volatilita 2.78
Beta 1.10
RSI 47.06
Cílová cena analytiků 26
Známka akcie (dle analytiků) 1.95
Insider ownership 2.94 %
Institutional ownership 73.86 %
Počet akcií 358.396M
Procento shortovaných akcií 5.79 %
Short ratio 6.61 %
Dividenda 0.00
Procentuální dividenda 0.00 %
Dividenda/Zisk N/A %
Obchodovaná od 2018
Země Canada

Finanční výsledky akcie BHC

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$8,601$8,380$8,724$9,674$10,447$8,206
Cost Of Goods Sold$2,350$2,351$2,548$2,611$2,585$2,236
Gross Profit$6,251$6,029$6,176$7,063$7,862$5,970
Research And Development Expenses$471$413$361$421$334$246
SG&A Expenses$2,554$2,473$2,582$2,810$2,700$2,026
Other Operating Income Or Expenses$-1,426$29$642$-60$-272$277
Operating Expenses$8,804$10,764$8,622$10,240$8,920$6,205
Operating Income$-203$-2,384$102$-566$1,527$2,001
Total Non-Operating Income/Expense$-1,634$-1,770$-1,843$-1,869$-1,682$-947
Pre-Tax Income$-1,837$-4,154$-1,741$-2,435$-155$1,054
Income Taxes$-54$-10$-4,145$-27$133$174
Income After Taxes$-1,783$-4,144$2,404$-2,408$-288$880
Other Income------
Income From Continuous Operations$-1,783$-4,144$2,404$-2,408$-288$880
Income From Discontinued Operations------
Net Income$-1,788$-4,148$2,404$-2,409$-292$881
EBITDA$1,935$514$3,111$2,418$4,139$3,685
EBIT$-203$-2,384$102$-566$1,527$2,001
Basic Shares Outstanding352351350347343335
Shares Outstanding352351352347343342
Basic EPS$-5.08$-11.81$6.86$-6.94$-0.85$2.63
EPS - Earnings Per Share$-5.08$-11.81$6.83$-6.94$-0.85$2.58
# 2020 2019 2018 2017 2016 2015
Current Ratio1.11541.09781.1121.40681.03651.5255
Long-term Debt / Capital0.9560.89530.80940.90160.83390.7382
Debt/Equity Ratio22.79498.63414.28069.16085.15642.8193
Gross Margin72.677671.945170.793273.010175.256172.7517
Operating Margin-2.3602-28.44871.1692-5.850714.616624.3846
EBIT Margin-2.3602-28.44871.1692-5.850714.616624.3846
EBITDA Margin22.49746.133735.660324.994839.61944.9062
Pre-Tax Profit Margin-21.358-49.5704-19.9564-25.1706-1.483712.8443
Net Profit Margin-20.7883-49.498827.5562-24.9018-2.795110.7361
Asset Turnover0.2540.25790.23270.22220.21340.312
Inventory Turnover Ratio2.12292.51712.43132.46092.05652.5146
Receiveable Turnover4.6774.49334.09583.84353.8883.9532
Days Sales In Receivables78.041581.232189.116294.966493.879192.3309
ROE - Return On Equity-156.9542-147.211440.4442-73.9104-4.776916.2912
Return On Tangible Equity8.034818.5597-9.67027.66390.8088-5.7752
ROA - Return On Assets-5.2653-12.75396.4112-5.5319-0.58823.3454
ROI - Return On Investment-6.9117-15.40987.7103-7.2743-0.79354.2657
Book Value Per Share3.22218.045817.04579.366917.581116.1533
Operating Cash Flow Per Share-0.0097-2.23670.5002-0.5767-0.18423.524
Free Cash Flow Per Share-0.2986-11.34749.3644-0.0325-4.34597.269

Porovnání s konkurencí: Akcie BHC

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
BHC N/A 0.87 4.55 % -20.45 % -2,163.03 % 18.71 -6.98 %
Akcie ODT 0.00 N/A N/A % -91.40 % -96.44 % 0.82 N/A %
Akcie ODT 0.00 N/A N/A % -91.40 % -96.44 % 0.82 N/A %
Akcie ODT 0.00 N/A N/A % -91.40 % -96.44 % 0.82 N/A %
Akcie OMER N/A N/A -13.66 % -28.79 % 82.46 % -3.46 -187.04 %
Akcie OMER N/A N/A -13.66 % -28.79 % 82.46 % -3.46 -187.04 %
Akcie OMER N/A N/A -13.66 % -28.79 % 82.46 % -3.46 -187.04 %
Akcie OMER N/A N/A -13.66 % -28.79 % 82.46 % -3.46 -187.04 %
Akcie OMER N/A N/A -13.66 % -28.79 % 82.46 % -3.46 -187.04 %
Akcie OMER N/A N/A -13.66 % -28.79 % 82.46 % -3.46 -187.04 %

Nedávné obchody insiderů: Akcie BHC

Jméno Obchod Cena Objem
Joseph F Gordon
Pres, Co-Head Bausch, and Lomb/Int'l
Option
19 Feb 2020
$26.46 $138,703
William D. Humphries
President and Ortho-Dermatologics
Option
19 Feb 2020
$26.46 $553,305
Schutter Richard U De
Director
Nákup
3 Mar 2020
$21.00 $184,800
Christina Ackermann
EVP AND GENERAL COUNSEL
Nákup
9 Mar 2020
$18.25 $80,118
Eschenbach Andrew C. Von
Director
Nákup
10 Mar 2020
$18.18 $19,998
Thomas W. Sr. Ross
Director
Nákup
12 Mar 2020
$15.54 $38,850
John Paulson
Director
Nákup
12 May 2020
$16.65 $83,250,000
Holdings, L.P.Value Act Cap...
Nákup
5 Jun 2020
$19.24 $18,246,312
William D. Humphries
President and Ortho-Dermatologics
Prodej
8 Sep 2020
$16.17 $91,635
William D. Humphries
President and Ortho-Dermatologics
Option
23 Nov 2020
$14.38 $529,242
William D. Humphries
President and Ortho-Dermatologics
Option
4 Dec 2020
$14.38 $1,640,111

Diskuze k akciím BHC